Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
AdAM is a prospective, randomized, controlled, double-blinded, monocentric trial in patients receiving surgical therapy due to anal HPV infection. Aim of the study is to evaluate efficacy of combination therapy (surgical therapy + topical Imiquimod-therapy). It is planned to include 200 patients. 100 patients receive surgical therapy+ topical Imiquimod therapy, 100 patients receive surgical therapy + topical Placebo therapy
Epistemonikos ID: 9e74ea7f01158adb7e35af3e2be764623985173f
First added on: Mar 23, 2020